| 1 |
Kenneth A. Newlander |
Smithkline Beecham Limited |
4 |
| 1 |
William Henry Miller |
Smithkline Beecham Limited |
4 |
| 3 |
Jerry L. Adams |
Smithkline Beecham Limited |
3 |
| 3 |
John James Dougherty |
GE |
3 |
| 3 |
Siegfried B. Christensen, IV |
Smithkline Beecham Limited |
3 |
| 3 |
Mark A. Seefeld |
Affinium Pharmaceuticals |
3 |
| 3 |
Timothy A. Axness |
Interdigital Technology |
3 |
| 3 |
Bruce E. Tomczuk |
3-Dimensional Pharmaceuticals |
3 |
| #9 |
John A. Helgenberg |
Unisys |
2 |
| #9 |
Wendy Slavish |
Johnson & Johnson |
2 |
| #9 |
Katherine L. Widdowson |
Smithkline Beecham Limited |
2 |
| #9 |
Raymond L. Sharrah |
Streamlight |
2 |
| #9 |
Dai-Shi Su |
Sloan Kettering Institute For Cancer Research |
2 |
| #9 |
Gary W. Guenst |
Medtronic |
2 |
| #9 |
George C. Morton |
Bristol-Myers Squibb |
2 |
| #9 |
Neil D. Jenkins |
Carrier |
2 |
| #17 |
Lyn Hughes |
Rohm And Haas |
1 |
| #17 |
Steven B. Liebers |
Diversified Products |
1 |
| #17 |
Eric Steven Manas |
Pfizer |
1 |
| #17 |
Patrick G. Faulkner |
Smithkline Beecham Limited |
1 |
| #17 |
John H. Seibert |
Tyco Electronics Co. |
1 |
| #17 |
Stephen A. Koch |
Certainteed |
1 |
| #17 |
Mark D. Westmeyer |
Rohm And Haas |
1 |
| #17 |
Kelly M. Aubart |
Smithkline Beecham Limited |
1 |
| #17 |
Philip Anthony Harris |
Smithkline Beecham Limited |
1 |
| #17 |
Puvin Pichai |
Novus International |
1 |
| #17 |
Robert R. Singhaus, Jr. |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #17 |
Adam W. Sledeski |
Aventis Pharmaceuticals Products |
1 |
| #17 |
Steven J. Capriotti |
Unisys |
1 |
| #17 |
Michael Precopio |
— |
1 |
| #17 |
Kurt Davidson |
— |
1 |
| #17 |
Benoit J. Vanasse |
Aventis Pharmaceuticals Products |
1 |
| #17 |
Robert Joseph Leadley, Jr. |
Aventis Pharmaceuticals Products |
1 |
| #17 |
Glenn H. Stahl |
Pilling Weck Incorporated |
1 |
| #17 |
Mahase Nardeo |
Medical Components |
1 |
| #17 |
William P. McDonough |
Depuy Synthes Products |
1 |
| #17 |
Daniel Burch |
Smithkline Beeacham P.L.C. |
1 |
| #17 |
Marc Merritt |
— |
1 |
| #17 |
Virginia Ann Gates |
Amersham Plc |
1 |
| #17 |
Anthony J. Calise |
Georgia Tech Research |
1 |
| #17 |
Kenneth J. Holroyd |
Geneial |
1 |
| #17 |
Walter E. DeWolf, Jr. |
Affinium Pharmaceuticals |
1 |
| #17 |
Seth Grant |
Glaxosmithkline |
1 |
| #17 |
Peter A. Callais |
Arkema |
1 |
| #17 |
Kin T. Yu |
Rorer Pharmaceutical |
1 |
| #17 |
Symon G. Erskine |
Smithkline Beeacham P.L.C. |
1 |
| #17 |
James Raymond Brown |
Smithkline Beecham Limited |
1 |
| #17 |
Steven David Knight |
Cytokinetics |
1 |
| #17 |
Neil David Pearson |
Glaxo Group Limited |
1 |
| #17 |
Antony N. Shaw |
Glaxosmithkline |
1 |